Page last updated: 2024-09-04

cyc 202 and sesquiterpenes

cyc 202 has been researched along with sesquiterpenes in 2 studies

Compound Research Comparison

Studies (cyc 202)	Trials (cyc 202)	Recent Studies (post-2010) (cyc 202)	Studies (sesquiterpenes)	Trials (sesquiterpenes)	Recent Studies (post-2010) (sesquiterpenes)
979	7	393	17,489	536	7,668

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cory, AH; Cory, JG; Edwards, CC; Hall, JG	1
Canel, NG; Salamone, DF; Suvá, M	1

Other Studies

2 other study(ies) available for cyc 202 and sesquiterpenes

Article	Year
Inhibitors of diverse metabolic steps cause increased apoptosis in deoxyadenosine-resistant mouse leukemia L1210 cells that lack p53 expression: convergence at caspase-3 activation. Advances in enzyme regulation, 2003, Volume: 43 Topics: Androstadienes; Animals; Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Butyrates; Caspase 3; Caspases; Cell Cycle; Cell Line, Tumor; Coloring Agents; Deoxyadenosines; DNA Damage; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Genistein; Isoxazoles; Leflunomide; Mice; Models, Biological; Purines; RNA, Messenger; Roscovitine; Sesquiterpenes; Time Factors; Tumor Suppressor Protein p53; Wortmannin	2003
Effect of single and combined treatments with MPF or MAPK inhibitors on parthenogenetic haploid activation of bovine oocytes. Reproductive biology, 2019, Volume: 19, Issue:4 Topics: Animals; Benzamides; Cattle; Diphenylamine; Ethanol; Female; Ionomycin; Lactones; Maturation-Promoting Factor; Mitogen-Activated Protein Kinases; Oocytes; Parthenogenesis; Reproductive Techniques, Assisted; Roscovitine; Sesquiterpenes	2019

Article

Year

Inhibitors of diverse metabolic steps cause increased apoptosis in deoxyadenosine-resistant mouse leukemia L1210 cells that lack p53 expression: convergence at caspase-3 activation.

Advances in enzyme regulation, 2003, Volume: 43

Topics: Androstadienes; Animals; Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Butyrates; Caspase 3; Caspases; Cell Cycle; Cell Line, Tumor; Coloring Agents; Deoxyadenosines; DNA Damage; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Genistein; Isoxazoles; Leflunomide; Mice; Models, Biological; Purines; RNA, Messenger; Roscovitine; Sesquiterpenes; Time Factors; Tumor Suppressor Protein p53; Wortmannin

2003

Effect of single and combined treatments with MPF or MAPK inhibitors on parthenogenetic haploid activation of bovine oocytes.

Reproductive biology, 2019, Volume: 19, Issue:4

Topics: Animals; Benzamides; Cattle; Diphenylamine; Ethanol; Female; Ionomycin; Lactones; Maturation-Promoting Factor; Mitogen-Activated Protein Kinases; Oocytes; Parthenogenesis; Reproductive Techniques, Assisted; Roscovitine; Sesquiterpenes

2019